The CRTAC1 Protein in Plasma Is Associated With Osteoarthritis and Predicts Progression to Joint Replacement: A Large‐Scale Proteomics Scan in Iceland
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective: Biomarkers for diagnosis and progression of osteoarthritis (OA) are lacking. This study was undertaken to identify circulating biomarkers for OA that could predict disease occurrence and/or progression to joint replacement. Methods: Using the SomaScan platform, we measured 4,792 proteins in plasma from 37,278 individuals, of whom 12,178 individuals had OA and 2,524 had undergone joint replacement. We performed a case–control study for identification of potential protein biomarkers for hip, knee, and/or hand OA, and a prospective study for identification of biomarkers for joint replacement. Results: Among the large panel of plasma proteins assessed, cartilage acidic protein 1 (CRTAC1) was the most strongly associated with both OA diagnosis (odds ratio 1.46 [95% confidence interval 1.41–1.52] for knee OA, odds ratio 1.36 [95% confidence interval 1.29–1.43] for hip OA, and odds ratio 1.33 [95% confidence interval 1.26–1.40] for hand OA) and progression to joint replacement (hazard ratio 1.40 [95% confidence interval 1.30–1.51] for knee replacement and hazard ratio 1.31 [95% confidence interval 1.19–1.45] for hip replacement). Patients with OA who were in the highest quintile of risk of joint replacement, based on known risk factors (i.e., age, sex, and body mass index) and plasma CRTAC1 level, were 16 times more likely to undergo knee replacement within 5 years of plasma sample collection than those in the lowest quintile, and 6.5 times more likely to undergo hip replacement. CRTAC1 was not associated with other types of inflammatory arthritis. A specific protein profile was identified in those patients who had undergone joint replacement prior to plasma sample collection. Conclusion: Through a hypothesis‐free approach, we identified CRTAC1 in plasma as a novel promising candidate biomarker for OA that is both associated with occurrence of OA and predictive of progression to joint replacement. This biomarker might also be useful in the selection of suitable patients for clinical trial enrollment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and burden of osteoarthritis
Litwic, A., Edwards, M. H., Dennison, E. M., & Cooper, C. (2013) · British Medical Bulletin · doi:10.1093/bmb/lds038 · Cited by 1,315
arcOGEN Consortium, Tachmazidou, I., Hatzikotoulas, K., Southam, L., Esparza-Gordillo, J., Haberland, V., Zheng, J., Johnson, T., Koprulu, M., Zengini, E., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0327-1 · Cited by 516 · cited 2×
“Furthermore, in large metaanalyses of OA, no association with sequence variants at the CRTAC1 locus has been described (14,15).”
BackgroundMethodSelection against variants in the genome associated with educational attainment
Kong, A., Frigge, M. L., Thorleifsson, G., Stefansson, H., Young, A. I., Zink, F., Jonsdottir, G. A., Okbay, A., Sulem, P., Masson, G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612113114 · Cited by 168 · cited 1×
“uk) (14) and calculated the risk scores for genotyped Icelanders, using 600,000 common variants and LDpred software, essentially as previously described (20).”
MethodSelf-citationDevelopment and use of biochemical markers in osteoarthritis: current update
Bay-Jensen, A. C., Thudium, C. S., & Mobasheri, A. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000467 · Cited by 56
Cited by
Early-stage symptomatic osteoarthritis of the knee — time for action
Mahmoudian, A., Lohmander, L. S., Mobasheri, A., Englund, M., & Luyten, F. P. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00673-4 · Cited by 455
Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression
Szilagyi, I. A., Vallerga, C. L., Boer, C. G., Schiphof, D., Ikram, M. A., Bierma-Zeinstra, S. M. A., & van Meurs, J. B. J. (2023) · Rheumatology · doi:10.1093/rheumatology/keac415 · Cited by 51
Osteoarthritis Year in Review 2024: Molecular biomarkers of osteoarthritis
Welhaven, H. D., Welfley, A. H., & June, R. K. (2025) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2024.10.003 · Cited by 39
Styrkarsdottir, U., Lund, S. H., Thorleifsson, G., Saevarsdottir, S., Gudbjartsson, D. F., Thorsteinsdottir, U., & Stefansson, K. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42376 · Cited by 34
Self-citation
Metadata
- Authors
- Styrkarsdottir, U., Lund, S. H., Saevarsdottir, S., Magnusson, M. I., Gunnarsdottir, K., Norddahl, G. L., Frigge, M. L., Ivarsdottir, E. V., Bjornsdottir, G., Holm, H., Thorgeirsson, G., Rafnar, T., Jonsdottir, I., Ingvarsson, T., Jonsson, H., Sulem, P., Thorsteinsdottir, U., Gudbjartsson, D., & Stefansson, K.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2021-09-28
- Volume
- 73
- Issue
- 11
- Pages
- 2025-2034
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W3162666314
- Cited by
- 63
- References
- 4
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The CRTAC1 Protein in Plasma Is Associated With Osteoarthritis and Predicts Progression to Joint Replacement: A Large‐Scale Proteomics Scan in Iceland. https://app.cochat.ai/papers/10.1002/art.41793
- The paper
- Styrkarsdottir, U., Lund, S. H., Saevarsdottir, S., Magnusson, M. I., Gunnarsdottir, K., Norddahl, G. L., Frigge, M. L., Ivarsdottir, E. V., Bjornsdottir, G., Holm, H., Thorgeirsson, G., Rafnar, T., Jonsdottir, I., Ingvarsson, T., Jonsson, H., Sulem, P., Thorsteinsdottir, U., Gudbjartsson, D., & Stefansson, K. (2021). The CRTAC1 Protein in Plasma Is Associated With Osteoarthritis and Predicts Progression to Joint Replacement: A Large‐Scale Proteomics Scan in Iceland. Arthritis & Rheumatology. https://doi.org/10.1002/art.41793
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.